top of page


Sally Adua, PhD is a Senior Associate at the Global BioAccess Fund where her duties include conducting scientific and commercial due diligence to support the Fund’s investment decisions. She has a background in strategy consulting and basic science research. 


Prior to joining the Fund, Sally worked as a Project Leader at Boston Consulting Group focusing on providing strategic recommendations to R&D organizations of global biopharma companies across therapeutic areas. She was also a Fellow at Canaan Partners where she assisted in identifying potential investments and opportunities for the healthcare portfolio of Canaan Partners. Additionally, she held a position as a Blavatinik Associate and provided business and development expertise to Yale faculty members seeking funding for novel biotech companies. 


Sally earned her PhD in Cancer Biology from Yale University. She has a B.S. in Biology from Providence College.  

bottom of page